Medicine and Dentistry
Endothelin System
100%
Expectation
100%
Cardiovascular Disease
100%
Receptor Antagonist
50%
Experience
33%
Endothelin 1
16%
Therapeutic Procedure
16%
Animal Study
16%
Chronic Kidney Disease
16%
Sitaxentan
16%
Tenidap
16%
Vasoconstrictor
16%
Pulmonary Hypertension
16%
In Vitro
16%
Disease
16%
Subarachnoid Hemorrhage
16%
ACE Inhibitor
16%
Bosentan
16%
Resistant Hypertension
16%
Cells
16%
Motivation
16%
Heart Failure
16%
Pathogenesis
16%
Receptor
16%
Connective Tissue Disease
16%
Man
16%
Biochemistry, Genetics and Molecular Biology
Endothelin
100%
Clinical Trial
100%
Expectation
100%
Electric Potential
50%
Receptor Antagonist
50%
Experience
33%
Enzyme Inhibitor
16%
Bosentan
16%
Comprehension
16%
Contrast
16%
Development
16%
Ambrisentan
16%
Animal Experiment
16%
Transgenics
16%
Endothelin 1
16%
Motivation
16%
Pharmacology, Toxicology and Pharmaceutical Science
Endothelin
100%
Receptor Antagonist
50%
Pulmonary Hypertension
16%
Pathogenesis
16%
Dipeptidyl Carboxypeptidase Inhibitor
16%
Sitaxentan
16%
Bosentan
16%
Vasoconstrictor Agent
16%
Ambrisentan
16%
Resistant Hypertension
16%
Chronic Kidney Failure
16%
Diseases
16%
Heart Failure
16%
Endothelin 1
16%
Connective Tissue Disease
16%
Animal
16%
Receptor
16%
Subarachnoid Hemorrhage
16%
Tenidap
16%